Q - InfuSystem Holdings,
For the period ended Jun 30, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 5, 2025
INFU$15.28+4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
-Unaudited Condensed Consolidated Statements of Stockholders’ Equity for
CONDENSED CONSOLIDATED STATEMENTS OF
STOCKHOLDERS’ EQUITY
| Common Stock · Additional Paid in Capital · Retained Deficit · Accumulated Other Comprehensive Income · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| (in thousands) · Shares · Par Value Amount | ||||||
| Balances at March 31, 2024 | 21,290 | $2 | $110,715 | $(59,737) | $1,296 | $52,276 |
| Shares issued upon restricted stock vesting and option exercise | 105 | — | 39 | — | — | 39 |
| Stock-based compensation expense | — | — | 998 | — | — | 998 |
| Common stock repurchased as part of share repurchase program | (41) | — | — | (283) | — | (283) |
| Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation | (39) | — | (259) | — | — | (259) |
| Other comprehensive loss | — | — | — | — | (1) | (1) |
| Net income | — | — | — | 717 | — | 717 |
| Balances at June 30, 2024 | 21,315 | $2 | $111,493 | $(59,303) | $1,295 | $53,487 |
| Balances at March 31, 2025 | 20,974 | $2 | $114,898 | $(60,622) | $870 | $55,148 |
| Shares issued upon restricted stock vesting and option exercise | 85 | — | — | — | — | — |
| Stock-based compensation expense | — | — | 661 | — | — | 661 |
| Common stock repurchased as part of share repurchase program | (597) | — | — | (3,500) | — | (3,500) |
| Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation | (36) | — | (221) | — | — | (221) |
| Other comprehensive loss | — | — | — | — | (153) | (153) |
| Net income | — | — | — | 2,599 | — | 2,599 |
| Balances at June 30, 2025 | 20,426 | $2 | $115,338 | $(61,523) | $717 | $54,534 |
| Balances at December 31, 2023 | 21,197 | $2 | $109,837 | $(58,625) | $1,088 | $52,302 |
| Shares issued upon restricted stock vesting and option exercise | 211 | — | 39 | — | — | 39 |
| Stock-based compensation expense | — | — | 2,055 | — | — | 2,055 |
| Employee stock purchase plan | 26 | — | 186 | — | — | 186 |
| Common stock repurchased as part of share repurchase program | (41) | — | — | (283) | — | (283) |
| Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation | (78) | — | (624) | — | — | (624) |
| Other comprehensive income | — | — | — | — | 207 | 207 |
| Net loss | — | — | — | (395) | — | (395) |
| Balances at June 30, 2024 | 21,315 | $2 | $111,493 | $(59,303) | $1,295 | $53,487 |
| Balances at December 31, 2024 | 21,272 | $2 | $113,868 | $(57,460) | $1,119 | $57,529 |
| Shares issued upon restricted stock vesting and option exercise | 164 | — | — | — | — | — |
| Stock-based compensation expense | — | — | 1,769 | — | — | 1,769 |
| Employee stock purchase plan | 35 | — | 159 | — | — | 159 |
| Common stock repurchased as part of share repurchase program | (979) | — | — | (6,395) | — | (6,395) |
| Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation | (66) | — | (458) | — | — | (458) |
| Other comprehensive loss | — | — | — | — | (402) | (402) |
| Net income | — | — | — | 2,332 | — | 2,332 |
| Balances at June 30, 2025 | 20,426 | $2 | $115,338 | $(61,523) | $717 | $54,534 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.